Transcatheter Arterial Embolization Using Imipenem/Cilastatin Sodium for Tendinopathy and Enthesopathy Refractory to Nonsurgical Management
Transcatheter Arterial Embolization Using Imipenem/Cilastatin Sodium for Tendinopathy and Enthesopathy Refractory to Nonsurgical Management
复制标题
DOI:
10.1016/j.jvir.2013.02.033
复制
发表时间:
2013-06-01
影响因子:
2.9
通讯作者:
Oguro, Sota
中科院分区:
文献类型:
--
作者:
Okuno, Yuji;Matsumura, Noboru;Oguro, Sota
Purpose: To evaluate the feasibility and effects of transcatheter arterial embolizatiori with imipenem/cilastatin sodium (CS) to treat tendinopathy and enthesopathy that are refractory to traditional nonsurgical management.Materials and Methods: Transcatheter arterial embolization with imipenem/CS as an embolic agent was performed in seven patients (five men; meat age, 51.7 y) with tendinopathy and enthesopathy (patellar tendinopathy, n = 1; rotator cuff tendinopathy, n = 2; plantar fasciitis, n = 1; lateral epicondylitis, n = 1; iliotibial band syndrome, n = 1; and, Achilles insertion tendinopathy, n = 1). All patients had unrelenting pain at the site of tendinopathy and enthesopathy before the procedure. Technical success, adverse events, and changes in visual analog scale (VAS) scores Were assessed.Results: All procedures were technically successful, and no major adverse events developed. Compared with before the procedure, mean VAS scores were. significantly decreased at 1 day, 1 week, and 1 and 4 months After the procedure (72.7 mm +/- 9.0 vs 17.4 +/- mm +/- 18.5, 16.0 mm +/- 18.1, 13.7 mm +/- 7.3, and 9.7 mm +/- 6.8, respectively; all P < .001).Conclusions: Transcatheter arterial embolization with imipenem/CS was feasible and effectively relieved unrelenting pain associated with tendinopathy and enthesopathy.